Research
Conforma Therapeutics Expands Cancer Collaborations With Duke Agreement
Published in Cancer Weekly, January 8th, 2002
The new agreement with Duke consolidates Conforma's position in the field of heat shock protein-90 (HSP90)-directed drugs. Under the agreement, Conforma obtains from Duke an exclusive license to novel screening technology, x-ray crystal structure information useful in the rational design of drugs directed against individual HSP90 family members, and a proprietary target for drug discovery.
In addition, under a sponsored research agreement, Conforma has initiated a research collaboration in the field of...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2002-01-08)
More Articles from Cancer Weekly
- Acute Leukemia
Second Stem Cell Transplant Effective After Relapse - Proliferation
New Inhibitor Arrests Growth, Induces Apoptosis To Regulate Cells - Cancer Therapies
Minimal Nutrition Might Control Some Prostate, Pancreatic Cancers - Chronic Myeloid Leukemia
Interferon Doesn't Affect Stem Cell Transplantation Outcome - Colon Cancer
Ridding Cells Of Heat Shock Protein 70 Enhances Tumor Immunogenicity - Liver Cancer
Testosterone Affects HBV-Related Hepatocellular Carcinoma Risk In Men - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
